Search

Search Results
Results 37871 - 37880 of 37911 for Tumors
  • TissueGnostics
    Supplier - 19 Jun 2017
    TissueGnostics (TG) is an Austrian company focusing on integrated solutions for high content and/or high throughput scanning and analysis of biomedical, veterinary, natural sciences and technical...
  • TEST-Hauptman-Woodward Medical Research Institute
    Supplier - 30 Dec 2023
    Hauptman-Woodward Medical Research Institute scientists have been committed to finding the fundamental causes of many diseases.
  • Hauptman-Woodward Medical Research Institute
    Supplier - 20 Dec 2023
    For more than half a century, Hauptman-Woodward Medical Research Institute scientists have been committed to finding the fundamental causes of many diseases.
  • Aventa Genomics
    Supplier - 4 Oct 2023
    Aventa Genomics, LLC, a joint venture between Arima Genomics, Inc., and Protean BioDiagnostics, Inc., is a CLIA certified lab committed to improving patient outcomes by using 3D Genomics tools to...
  • Pheon Therapeutics
    Supplier - 29 Oct 2019
    Developer of Antibody-Drug Conjugate (ADC) specialist intended for a wide range of hard-to-treat cancers.
  • Macrophage Directed Therapies Summit
    Supplier - 26 Jul 2019
    The inaugural Macrophage-directed Therapies Summit is the only platform dedicated to helping leaders from pharma, biotech and academic institutes to successfully achieve clinical proof of concept when...
  • Wikkon
    Supplier - 29 Jun 2013
    Wikkon was founded in 1996 with its mission to improve human health by delivering high-quality, competitively priced medical devices. Wikkon is now a leading manufacturer and marketer of...
  • Carcinotech
    Supplier - 30 Aug 2024
    Carcinotech is a MedTech company with expertise in manufacturing 3D printed living tumours using patient-derived biopsies, primary cells, immune cells and cancer stem cells. Carcinotech’s advanced...
  • Okomera
    Supplier - 27 Mar 2024
    Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies, pioneering automation and miniaturization of personalized tumor biopsy studies.
  • NK:IO Limited
    Supplier - 11 Jul 2023
    NK:IO reimagines cancer treatment. By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies targeting both haematological and...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback